CASTLEARK MANAGEMENT LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 201 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
CASTLEARK MANAGEMENT LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,347,785
-18.6%
39,182
-2.0%
0.12%
-8.4%
Q2 2023$2,884,144
+6.9%
40,002
+65.9%
0.13%
+12.0%
Q2 2020$2,697,000
-50.0%
24,115
-39.4%
0.12%
-49.1%
Q4 2018$5,397,000
-76.0%
39,775
-51.4%
0.23%
-64.3%
Q3 2018$22,453,000
+17.5%
81,800
-11.3%
0.64%
+9.7%
Q2 2018$19,104,000
+38.1%
92,215
+10.1%
0.59%
+34.2%
Q1 2018$13,836,000
+0.7%
83,776
-16.5%
0.44%
+6.1%
Q4 2017$13,740,000
+0.6%
100,340
-0.0%
0.41%
-3.7%
Q3 2017$13,663,000
+43.0%
100,350
+27.5%
0.43%
+37.5%
Q2 2017$9,552,000
-26.9%
78,680
-38.6%
0.31%
-21.0%
Q3 2016$13,074,000
-36.4%
128,097
-25.7%
0.40%
-39.8%
Q2 2016$20,562,000
-10.1%
172,400
-19.3%
0.66%
-8.1%
Q1 2016$22,869,000
+2.1%
213,551
+3.4%
0.71%
+6.1%
Q4 2015$22,397,000
+24.5%
206,576
-1.6%
0.67%
+16.2%
Q3 2015$17,985,000
-18.8%
209,986
-4.3%
0.58%
-2.2%
Q2 2015$22,150,000
+88.0%
219,520
+43.7%
0.59%
+108.5%
Q1 2015$11,779,000
-26.0%
152,750
-35.5%
0.28%
-37.3%
Q3 2014$15,919,000
+152.4%
236,646
+133.7%
0.45%
+160.3%
Q2 2014$6,308,000
-60.4%
101,266
-57.2%
0.17%
-61.6%
Q1 2014$15,919,000
+42.7%
236,646
+11.5%
0.45%
+39.8%
Q4 2013$11,159,000
+52.9%
212,157
+8.8%
0.32%
+33.9%
Q2 2013$7,296,000195,0850.24%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders